About
Mission & Vision
Who we are
Atlas Molecular Pharma is a clinical-stage biotech company based in Biscay, Spain, founded in 2015 as a spin-off of CIC bioGUNE. ATLAS discovers and develops pharmacological chaperones for rare and ultra-rare diseases.
Our model is to advance our programs to clinical inflection points and license them to biotech and pharma partners able to bring treatments to patients worldwide.
Mission
Our mission is to bring treatments to patients with rare and ultra-rare diseases where few or no effective options exist. We pursue this through a science-led, efficient development model built on pharmacological chaperones and targeted drug repurposing.
Vision
Our vision is to be a partner of choice in rare disease, turning academic science into clinical-stage programs that partners can take forward.